LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 196

Search options

  1. Article ; Online: Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience.

    Bahap-Kara, Melda / Duran, Emine / Bayraktar-Ekincioglu, Aygin / Karadag, Omer

    Internal and emergency medicine

    2023  Volume 18, Issue 3, Page(s) 791–799

    Abstract: Biosimilars offer cost-effective and safe treatment options both for patients and healthcare systems. CT-P10 is the first biosimilar of rituximab approved in Europe for use in all indications of originator rituximab (oRTX). This study aimed to provide ... ...

    Abstract Biosimilars offer cost-effective and safe treatment options both for patients and healthcare systems. CT-P10 is the first biosimilar of rituximab approved in Europe for use in all indications of originator rituximab (oRTX). This study aimed to provide real-life data on treatment changes and adverse events in patients who received oRTX or CT-P10. We retrospectively reviewed treatment-related adverse events [infusion-related reactions (IRRs), infections, hypogammaglobulinemia] in patients treated with at least one dose of oRTX (MabThera
    MeSH term(s) Humans ; Rituximab/adverse effects ; Biosimilar Pharmaceuticals/adverse effects ; Agammaglobulinemia/chemically induced ; Agammaglobulinemia/drug therapy ; Retrospective Studies ; Treatment Outcome
    Chemical Substances Rituximab (4F4X42SYQ6) ; CT-P10 ; Biosimilar Pharmaceuticals
    Language English
    Publishing date 2023-02-24
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-023-03222-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.

    Durmus, Oyku / Akdogan, Neslihan / Karadag, Omer / Gokoz, Ozay

    Dermatologic therapy

    2022  Volume 35, Issue 5, Page(s) e15363

    MeSH term(s) BNT162 Vaccine ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Dermatitis, Exfoliative ; Humans ; Psoriasis/diagnosis ; Psoriasis/drug therapy ; RNA, Messenger ; Vaccines, Synthetic ; mRNA Vaccines
    Chemical Substances COVID-19 Vaccines ; RNA, Messenger ; Vaccines, Synthetic ; mRNA Vaccines ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2022-02-14
    Publishing country United States
    Document type Letter
    ZDB-ID 1354801-3
    ISSN 1529-8019 ; 1396-0296
    ISSN (online) 1529-8019
    ISSN 1396-0296
    DOI 10.1111/dth.15363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Comment on: Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry by Nguyen et al.

    Bilgin, Emre / Karadağ, Ömer

    Clinical and experimental rheumatology

    2020  Volume 39 Suppl 128, Issue 1, Page(s) 8

    MeSH term(s) Antibodies, Antineutrophil Cytoplasmic ; Humans ; Microscopic Polyangiitis/diagnosis ; Microscopic Polyangiitis/drug therapy ; Microscopic Polyangiitis/epidemiology ; Registries
    Chemical Substances Antibodies, Antineutrophil Cytoplasmic
    Language English
    Publishing date 2020-09-29
    Publishing country Italy
    Document type Letter ; Comment
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Management of Behcet's syndrome.

    Karadag, Omer / Bolek, Ertugrul Cagri

    Rheumatology (Oxford, England)

    2020  Volume 59, Issue Suppl 3, Page(s) iii108–iii117

    Abstract: Behcet's syndrome (BS) is a variable vessel vasculitis with heterogeneous clinical features. Skin, mucosa and joint involvement can cause impairment of quality of life but do not cause permanent damage whereas untreated eye, vascular, nervous system and ... ...

    Abstract Behcet's syndrome (BS) is a variable vessel vasculitis with heterogeneous clinical features. Skin, mucosa and joint involvement can cause impairment of quality of life but do not cause permanent damage whereas untreated eye, vascular, nervous system and gastrointestinal system involvement can cause serious damage and even death. Management of BS as a multidisciplinary team enables a faster and more accurate diagnosis and well-integrated treatment strategies. Corticosteroids are the mainstay of therapy. Colchicine, AZA, ciclosporin-A, cyclophosphamide, IFN alpha, and tumour necrosis factor alpha inhibitors are other agents used as induction and/or maintenance therapy. Although biologic agents have been increasingly used, there are still unmet needs. Head-to-head comparison studies of some therapeutic options (e.g. TNF inhibitors vs IFN alpha in uveitis) are required. Novel therapeutic agents in the pipeline could change the standard of care for BS in the future.
    MeSH term(s) Algorithms ; Behcet Syndrome/complications ; Behcet Syndrome/drug therapy ; Humans
    Language English
    Publishing date 2020-04-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keaa086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cryoglobulinemic vasculitis: having giant steps; but there are still unanswered questions.

    Karadag, Omer / Duran, Emine

    Internal and emergency medicine

    2020  Volume 16, Issue 1, Page(s) 33–35

    MeSH term(s) Antibodies, Monoclonal, Murine-Derived ; Biosimilar Pharmaceuticals ; Calcium Carbonate ; Cryoglobulinemia/complications ; Cryoglobulinemia/diagnosis ; Humans ; Rituximab ; Vasculitis/diagnosis
    Chemical Substances Antibodies, Monoclonal, Murine-Derived ; Biosimilar Pharmaceuticals ; CT-P10 ; Rituximab (4F4X42SYQ6) ; Calcium Carbonate (H0G9379FGK)
    Language English
    Publishing date 2020-09-04
    Publishing country Italy
    Document type Journal Article ; Comment
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-020-02481-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.

    Duran, Emine / Yildirim, Beste Ekin Sandalcı / Karadağ, Ömer

    Clinical and experimental rheumatology

    2021  Volume 41 Suppl 135, Issue 9, Page(s) 8

    MeSH term(s) Humans ; Rituximab/adverse effects ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/drug therapy ; Antibodies, Monoclonal, Humanized/adverse effects ; Antirheumatic Agents/adverse effects ; Treatment Outcome
    Chemical Substances Rituximab (4F4X42SYQ6) ; tocilizumab (I031V2H011) ; Tumor Necrosis Factor Inhibitors ; Antibodies, Monoclonal, Humanized ; Antirheumatic Agents
    Language English
    Publishing date 2021-09-07
    Publishing country Italy
    Document type Letter ; Comment
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/85mraz
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Sebastiani et al.

    Bilgin, Emre / Oral, Hakan / Damadoğlu, Ebru / Karadağ, Ömer

    Clinical and experimental rheumatology

    2021  Volume 39 Suppl 129, Issue 2, Page(s) 196

    MeSH term(s) Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy ; Antibodies, Antineutrophil Cytoplasmic ; Bronchiolitis ; Humans
    Chemical Substances Antibodies, Antineutrophil Cytoplasmic
    Language English
    Publishing date 2021-03-25
    Publishing country Italy
    Document type Letter ; Comment
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/yj41kj
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Iliac artery aneurysm in Behçet's syndrome: collaborative management is essential.

    Bilgin, Emre / Sayinalp, Basak / Eldem, Gonca / Karadag, Omer

    Rheumatology (Oxford, England)

    2021  Volume 60, Issue Suppl 3, Page(s) iii32–iii34

    MeSH term(s) Adult ; Behcet Syndrome/complications ; Humans ; Iliac Aneurysm/diagnostic imaging ; Iliac Aneurysm/etiology ; Iliac Aneurysm/therapy ; Male
    Language English
    Publishing date 2021-06-17
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keab038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda.

    Karadag, Omer / Jayne, David J

    Clinical and experimental rheumatology

    2018  Volume 36 Suppl 111, Issue 2, Page(s) 135–142

    Abstract: Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and disease course. Historical approaches to classification and diagnostic terminology are reviewed. Since differentiation of PAN from ... ...

    Abstract Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and disease course. Historical approaches to classification and diagnostic terminology are reviewed. Since differentiation of PAN from microscopic polyangiitis (MPA) and other ANCA vasculitides by the Chapel Hill conference statements, and with hepatitis associated PAN defined as a secondary vasculitis, the phenotyping and subclassification of PAN has received little attention. Monogenic disorders similar to PAN have been described (familial Mediterranean fever, Adenosine Deaminase-2 deficiency), and cutaneous PAN and single organ vasculitis, discussed. The overlapping phenotypes between PAN and other primary vasculitic syndromes and subphenotypes within PAN are explored. This work will underpin development of newer treatment regimens and future genetic and related aetiologic studies.
    MeSH term(s) Disease Progression ; History, 19th Century ; History, 20th Century ; History, 21st Century ; Humans ; Phenotype ; Polyarteritis Nodosa/classification ; Polyarteritis Nodosa/diagnosis ; Polyarteritis Nodosa/history ; Polyarteritis Nodosa/physiopathology ; Research
    Language English
    Publishing date 2018-03
    Publishing country Italy
    Document type Historical Article ; Journal Article ; Review
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease' by Wallace

    Yardımcı, Gözde Kübra / Yıldırım, Beste Ekin Sandalcı / Farisoğulları, Bayram / Kilic, Levent / Karadag, Omer

    Annals of the rheumatic diseases

    2022  Volume 82, Issue 12, Page(s) e230

    MeSH term(s) Humans ; United States ; Rheumatology ; Immunoglobulin G4-Related Disease/diagnosis ; Rheumatic Diseases/diagnosis
    Language English
    Publishing date 2022-07-11
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2022-222191
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top